↓ Skip to main content

Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)

Overview of attention for article published in BMC Cancer, October 2015
Altmetric Badge

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
16 Mendeley